Bintrafusp Alfa in Previously Treated Patients With R/M Non-keratinizing NPC
Condition(s):Nasopharyngeal Carcinoma; Recurrent Carcinoma; Metastatic Cancer; Non-keratinizing CarinomaLast Updated:October 27, 2022Active, not recruiting
Hide Studies Not Open or Pending
Condition(s):Nasopharyngeal Carcinoma; Recurrent Carcinoma; Metastatic Cancer; Non-keratinizing CarinomaLast Updated:October 27, 2022Active, not recruiting
Condition(s):Mesothelioma; LungLast Updated:September 7, 2023Recruiting
Condition(s):NeoplasmsLast Updated:April 25, 2023Active, not recruiting
Condition(s):Biliary Tract Cancer; CholangiocarcinomaLast Updated:May 23, 2022Terminated
Condition(s):Squamous Cell Carcinoma of Head and NeckLast Updated:April 6, 2022Terminated
Condition(s):Advanced Lung Non-Small Cell Carcinoma; Stage III Lung Cancer AJCC v8; Stage IIIA Lung Cancer AJCC v8; Stage IIIB Lung Cancer AJCC v8; Stage IIIC Lung Cancer AJCC v8; Stage IV Lung Cancer AJCC v8; Stage IVA Lung Cancer AJCC v8; Stage IVB Lung Cancer AJCC v8Last Updated:January 10, 2024Terminated
Condition(s):Triple Negative Breast NeoplasmsLast Updated:April 10, 2023Terminated
Condition(s):Lung Cancer; CancerLast Updated:March 18, 2024Active, not recruiting
Condition(s):Uterine Cervical NeoplasmsLast Updated:October 23, 2023Completed
Condition(s):Ovarian CancerLast Updated:July 13, 2022Not yet recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.